This guest post by JM Wilkinson and Kelly S. Davidge of Kirkstall Ltd. highlights an emerging technology, organotypic cell cultures.
Cell culture has come a long way in the last 20 years. 3D is rapidly replacing 2D (plated cells on cover slips) and now perfusion based systems with gentle flow of media are improving proliferation rates, control of differentiation and cell function. For in vitro safety and efficacy testing the goal is organotypic behaviour where the cell metabolism accurately reflects what happens in the human body. However some of the techniques also have direct relevance for stem cell research too. In this note we discuss some of the important factors that help to steer stem cell differentiation and could deliver mature cells with low batch to batch variation and a far more homogeneous population. Continue reading Guest Post: Role of the Physio-chemical Environment in Steering Stem Cell Differentiation
How to Calculate a Market Size: Bottom-Up versus Top-Down Approaches
An area in which BioInformant specializes is market size determination. ‘How big is the market’ is a vital question, because knowing the market size empowers decision-makers to:
- Determine whether a market opportunity merits investment
- Determine the growth capacity possible within a market
- Identify market segments of interest
- Set sales performance goals
Continue reading The Definitive Guide to Calculating Market Size
Six months ago, we proudly announced our partnership with Save the Cord Foundation in launching an awareness campaign called Cord Blood Banking Awareness: Educating America and the World. This campaign aims to educate currently expecting parents, as well as future parents, grandparents, siblings, and friends, about the medical benefits of cord blood preservation. Below is a collection of facts that aid our efforts in spreading awareness.
Continue reading Complete Year-to-Date Collection of Cord Blood Banking Awareness Facts
Stay alert to the latest and greatest on stem cells. Enjoy this week’s “3 Bullet Thursday,” a weekly post that we do to update you on interesting and important events within the world of stem cells.
(1) From film to stem cells: If we’ve ever seen a full-scale shift in company focus, this is it! Fujifilm establishes “Cellular Dynamics International Japan” to launch IPSC business for drug discovery support in Japan
(2) Will stem cells transform society in other areas than medicine? Check out the article “Is In Vitro Meat the Future of Food?” It discusses how myosatellite stem cells can produce muscle tissue via stem cell culture, and how the first in vitro burger was funded by Google co-founder Sergey Brin!
Continue reading 3 Bullet Thursday | Stem Cells (October 1, 2015)
The field of stem cell research has boomed over the past twelve months, bringing to light new ideas for treatments and applications. Here at BioInformant, we strive to do our best to provide you with the most up to date information related to the industry. As a supplement to our monthly round-ups, we thought it would be important to share the top ten most shared stem cell articles from the past year.
Continue reading Top 10 Most Shared Stem Cell Articles of the Past 12 Months
Stay alert to the latest and greatest on stem cells. Enjoy this week’s “3 Bullet Thursday,” a weekly post that we do to update you on interesting and important findings within the world of stem cells.
1) These three countries deserve a mention for their recent stem cell innovation:
Continue reading 3 Bullet Thursday | Stem Cells (Sept 24, 2015)
Did you know that BioInformant (@StemCellMarket) is the fastest growing stem cell account on Twitter? Check out our recent Twitter analytics to see our organic followers for the past 28 days.
Or, click here to follow us on Twitter and instantly get critical stem cell and cord blood market news, right to your feed. It’s the only site through which we release all of our free and premium (paid) stem cell market news. Continue reading Did you know that BioInformant is the fastest growing stem cell account on Twitter?
BioInformant is honored to be a sponsor for the upcoming “Biorepositories and Sample Management Summit” in Boston, Massachussetts, over October 12-14, 2015. This 3-day event promises to be the most interactive biobanking community event of the year.
Continue reading BioInformant is Honored to Sponsor the Biorepositories and Sample Management Summit
Recently, BioInformant released an article titled, “Do You Know the Top 5 iPS Cell Influencers (Right Now)?” In it, we named the five most important thought leaders that are driving therapeutic and commercial progress with induced pluripotent stem cells (iPS cells) right now in 2015. One of the important individuals that we highlighted was Dr. Robert Lanza, Chief Scientific Officer of Ocata Therapeutics.
In response to this article, Ocata Therapeutics released a press release announcing that “Dr. Robert Lanza, Chief Scientific Officer of Ocata Therapeutics has been awarded the honor of iPSC industry influencer by BioInformant, a leading research firm serving the stem cell sector.” Continue reading Dr. Robert Lanza, Chief Scientific Officer of Ocata Therapeutics Honored as iPSC Industry Influencer by BioInformant
Cord Blood Registry was the first cord blood bank to begin offering umbilical cord tissue storage within the United States, a service which it initiated in July 2010. Now, nearly half of private U.S. cord blood banks offer the service. A more in-depth analysis of the rate of market penetration within the U.S. is given below. When an analysis of cord tissue storage was first completed by BioInformant in 2013, only nine companies where offering the service in the United States. These companies are shown in the table below. Continue reading Market Penetration for Umbilical Cord Tissue Storage within the U.S.
What is Dental Stem Cell Storage?
Biobanking is the storage of human stem cells for personal or medical use at a later point in time. There are many types of biobanking that exist, including cord blood stem cell storage, adipose-derived stem cell storage, storage of bone marrow and peripheral blood, and more. In each situation, the sample is stored for a prolonged period of time, because the stem cells contained in the unit may be required for future medical use. One of the more recent and lesser known types of biobanking is dental stem cell storage.
Continue reading 8 Companies Competing in the Dental Stem Cell Storage Market
Currently, it costs a public bank approximately USD $2,000 to collect, test, and process a unit of cord blood for storage. In order to accept donations at no cost, public banks require income to support themselves. This income can come from federal funding, the profit margin of private banking, or from selling donated cord blood units for research. Alternatively, it can come from a combination of the above.
Continue reading Do You Understand How Public Cord Blood Banking is Funded?